| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Porcu, Luca |
| dc.contributor.author | Cortés Castan, Javier |
| dc.contributor.author | Miceli, Rosalba |
| dc.contributor.author | Di Cosimo, Serena |
| dc.contributor.author | Malfettone, Andrea |
| dc.date.accessioned | 2021-09-10T10:06:39Z |
| dc.date.available | 2021-09-10T10:06:39Z |
| dc.date.issued | 2020-07-10 |
| dc.identifier.citation | Di Cosimo S, Porcu L, Malfettone A, Cortés J, Miceli R. Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. Front Oncol. 2020 Jul 10;10:1223. |
| dc.identifier.issn | 2234-943X |
| dc.identifier.uri | https://hdl.handle.net/11351/6298 |
| dc.description | COVID-19; Cancer care; Patient guidance |
| dc.description.abstract | A Commentary on:
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
By Yu, J., Ouyang, W., Chua, M. L. K., and Xie, C. (2020). JAMA Oncol. doi: 10.1001/jamaoncol.2020.0980:ca_ES |
| dc.language.iso | eng |
| dc.publisher | Frontiers Media |
| dc.relation.ispartofseries | Frontiers in Oncology;10 |
| dc.rights | Attribution 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
| dc.source | Scientia |
| dc.subject | Càncer - Xina |
| dc.subject | COVID-19 (Malaltia) - Xina |
| dc.subject.mesh | Coronavirus Infections |
| dc.subject.mesh | Neoplasms |
| dc.subject.mesh | China |
| dc.title | Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.3389/fonc.2020.01223 |
| dc.subject.decs | infecciones por Coronavirus |
| dc.subject.decs | neoplasias |
| dc.subject.decs | China |
| dc.relation.publishversion | https://doi.org/10.3389/fonc.2020.01223 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Di Cosimo S] Biomarker Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. [Porcu L] Laboratory of Methodology for Clinical Research, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. [Malfettone A] Medica Scientia Innovation Research (MedSIR), New Jersey, United States. [Cortés J] Medica Scientia Innovation Research (MedSIR), New Jersey, United States. Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. IOB Institute of Oncology, Quiron Group, Madrid, Spain. IOB Institute of Oncology, Quiron Group, Barcelona, Spain. Vall d'Hebron Insititute of Oncology (VHIO), Barcelona, Spain. [Miceli R] Clinical Epidemiology and Trial Organization Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy |
| dc.identifier.pmid | 32754446 |
| dc.identifier.wos | 000555929000001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |
